Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data.
Vaeli Zadeh A, Dinparastisaleh R, Vaezi A, Bandyopadhyay D, Rubinstein I, Baig HZ, Calderon-Candelario R, Hashemi Shahraki A, Kawasaki T, Magnusson JM, Larsson LO, Sharafkhaneh A, Herazo-Maya JD, Lee AS, Mirsaeidi M.
Vaeli Zadeh A, et al. Among authors: mirsaeidi m.
Ann Am Thorac Soc. 2024 Mar;21(3):428-437. doi: 10.1513/AnnalsATS.202305-491OC.
Ann Am Thorac Soc. 2024.
PMID: 38134434
Free PMC article.